phoneCall Us: 1-800-296-4433
Insurers are Not Doctors
Skip to content
  • Home
  • Reference Information
  • News and Updates
  • About the Immune Deficiency Foundation
  • Contact

Reference Information

IDF Medical Advisory Committee Resolutions and Letters to Coventry
  • MAC Product Choice Resolution 1 26 2011
  • IDF MAC Resolution Formularies 11 16 2011
  • IDF Letter to HealthAmerica 10-11-11
  • IDF Letter to Coventry Health Care CEO 10-25-11
  • IDF Letter to Coventry Health Care CEO 11-14-11
Coventry Health Care Formulary Policy
  • Coventry Health Care Immunoglobulin Policy
  • Coventry Health Care Immunoglobulin Policy REVISED December 2011
  • Health America Coventry letter 9 30 2011
  • Coventry Health Care Formulary Policy Fact Sheet
  • Coventry Health Care Formulary Policy FAQ
  • IDF Responses to Coventry Statements
Articles on Adverse Reactions
  • IVIG REzai adverse reactions
  • IVIG Eight guiding principles
  • Clinical uses of IVIG 2005
  • Product Change Adverse Events CEI 2004
  • IVIG Tolerance-Feldmeyer 2010
  • Treatment Experiences and Preferences 2003
About Primary Immunodeficiency Diseases and Immunoglobulin Replacement Therapy
  • About Primary Immunodeficiency Diseases
  • Ig Therapy Chart October 2011

Press Releases

  • Press Release 1- November 22, 2011

 

Learn More About the Immune Deficiency Foundation

Tweet

Contact Info

phone1-800-296-4433

mailiand@primaryimmune.org

Get Social

Follow Us on Facebook Follow Us on Flickr Follow Us on Twitter Follow Us on YouTube

Subscribe to Updates


 

Recent News & Updates

  • International Patient Organisation for Primary Immunodeficiencies – New Position Statement on Access to Immunoglobulin Therapies
  • Provider Perspective: Formulary Changes Can Be Dangerous – Op-Ed from IDF Medical Director

The Immune Deficiency Foundation, 40 West Chesapeake Avenue, Suite 308 Towson, Maryland 21204 – Copyright © 2011 All Rights Reserved